MedPage Today on MSN56m
Metastasis-Directed Therapy for Prostate Cancer a Clear Winner in Meta-Analysis
Progression-free survival (PFS) in oligometastatic prostate cancer improved significantly with metastasis-directed therapy ...
UroToday35m
ASCO GU 2025: Evaluating Survival in Aggressive Variant Prostate Cancer Patients Undergoing PSMA Radioligand Therapy
(UroToday.com) The 2025 American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA was host to the Poster Session A: Prostate Cancer. Dr. Moein Moradpour ...